Amanat Acquisition Corp Announces Acquisition of Corxel Pharmaceuticals, Inc.
Acquiring Company
AMANAT ACQUISITION
Acquired Company
Corxel Pharmaceuticals
United StatesDelawareAngel InvestmentBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Amanat Acquisition Corp has entered into a Business Combination Agreement with Corxel Pharmaceuticals, Inc. and its parent company. The transaction is set to close in the first half of 2027, pending shareholder approvals and customary closing conditions. The merger aims to combine resources for the growth of Corxel.
Who to call at AMANAT ACQUISITION, and when
When AMANAT ACQUISITION changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day AMANAT ACQUISITION raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AMANAT ACQUISITION, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AMANAT ACQUISITION. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AMANAT ACQUISITION makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Corxel Pharmaceuticals?
Corxel Pharmaceuticals was acquired by AMANAT ACQUISITION, based in United States. The deal was reported on October 26, 2026. AMANAT ACQUISITION CORP is a Cayman Islands-based company focused on identifying, acquiring, and managing businesses in various sectors. AMANAT ACQUISITION is publicly traded (AMAN) and operates in Angel Investment.
When did AMANAT ACQUISITION acquire Corxel Pharmaceuticals?
AMANAT ACQUISITION's acquisition of Corxel Pharmaceuticals was reported on October 26, 2026. Amanat Acquisition Corp has entered into a Business Combination Agreement with Corxel Pharmaceuticals, Inc. and its parent company. The transaction is set to close in the first half of 2027, pending shareholder approvals and customary closing conditions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Corxel Pharmaceuticals do?
Corxel Pharmaceuticals, Inc. is a Delaware corporation engaged in the development and commercialization of pharmaceuticals. It focuses on innovative treatments to enhance patient care and improve health outcomes. It is privately held, operating in Biotechnology, and is based in Delaware.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.